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Objectives. This study sought to determine the prevalence,
characteristics, relation to clinical features and evolution of aortic
root disease and valve disease associated with ankylosing spon-
dylitis (AKS).
Background. Aortic root disease and valve disease are common
in patients with AKS, but their clinical and prognostic implica-
tions have not been well defined.
Methods. Forty-four outpatients with AKS and 30 age- and
gender-matched healthy volunteers underwent initial transesoph-
ageal echocardiography and rheumatologic evaluations. Twenty-
five patients underwent clinical and echocardiographic follow-up
39 6 10 months later.
Results. Aortic root disease and valve disease were common in
patients (82%) as compared with controls (27%; p < 0.001). Aortic
root thickening, increased stiffness and dilatation were seen in
61%, 61% and 25% of patients, respectively. Valve thickening (41%
for the aortic and 34% for the mitral valve) manifested predom-
inantly (74%) as nodularities of the aortic cusps and basal
thickening of the anterior mitral leaflet, forming the characteris-
tic subaortic bump. Valve regurgitation was seen in almost half of
patients, and 40% had moderate lesions. Except for the duration
of AKS, aortic root disease and valve disease were unrelated to the
activity, severity or therapy of AKS. During follow-up of 25
patients, in up to 24% new aortic root or valve abnormalities
developed, in 12% existing valve regurgitation worsened signifi-
cantly and in 20% abnormalities resolved. Twenty percent of
patients developed heart failure, underwent valve replacement,
had a stroke or died, as compared with 3% of control subjects.
Conclusions. Aortic root disease and valve disease are common
in patients with AKS, are unrelated to clinical features of AKS,
can resolve or progress over time and are associated with clini-
cally important cardiovascular morbidity.
(J Am Coll Cardiol 1998;32:1397–404)
©1998 by the American College of Cardiology
Aortic root disease and valve disease associated with ankylos-
ing spondylitis (AKS) include aortic root thickening and
dilatation, aortic cusp thickening and retraction, subaortic
bump and aortic and mitral regurgitation (1,2). Their preva-
lence ranges from 24% to 100% in postmortem series and 8%
to 31% by transthoracic echocardiography (3–7). However,
their clinical characterization, relation to clinical features of
AKS, evolution and prognostic implications are unclear (1,3,5–
7). Thus, in this study we sought to determine: (1) the
prevalence and characteristics of aortic root disease and valve
disease associated with AKS by transesophageal echocardiog-
raphy (TEE), (2) the association of heart disease with clinical
features of AKS, and (3) the evolution of aortic root disease
and valve disease during 3 years of follow-up.
Methods
Study population. From 1993 to 1997, 102 patients with
AKS were identified at two affiliated hospitals. We excluded 34
patients .60 years old because of the increased prevalence of
degenerative heart disease (8,9), 2 with history of rheumatic
fever or intravenous drug abuse, 4 with other spondyloar-
thropathies, and 18 because of refusal to participate or inability
to establish communication. The remaining 44 patients consti-
tuted our study group (71% of those eligible) and prospectively
underwent TEE and rheumatologic evaluations. They all de-
nied cardiac symptoms, but four (9%) were known to have
valve disease or a heart murmur (three had had valve surgery).
Thirty-nine patients tested for syphilis had negative results.
The results of TEE and clinical evaluations were compared
with those of 30 gender- and age-matched healthy volunteers
(Table 1). The Human Research Committee of the University
of New Mexico approved the study, and all subjects signed
informed consent.
Clinical evaluation. The activity, functional and global
indexes of AKS disease for the 6 months preceding TEE were
determined and each was scored from 0 to 10 (10–12). Spinal
disease was assessed by the metrology index of cervical, lumbar
and sacroiliac joint motion and scored from 0 to 10, the Stoke’s
lumbar spine radiographic score ranged from 0 to 72, and the
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Dale’s sacroiliitis radiographic staging ranged from 0 (normal
joints) to V (bilateral bony ankylosis) (13–15). An observer
unaware of clinical and TEE data determined the radiographic
scores.
A laboratory activity score of 0 to 5 was derived from five
abnormalities: anemia, leukopenia or leukocytosis, thrombo-
cytopenia, high erythrocyte sedimentation rate and high
C-reactive protein. This score resulted from at least three tests
performed within 12 months preceding TEE.
To assess the relation of immunoglobulin G and immuno-
globulin M anticardiolipin antibodies to cardiovascular dis-
ease, these antibodies were measured in 38 patients and
considered present when .22 or .10 IU, respectively, was
detected (16). Finally, the anti-inflammatory therapy for $12
months preceding the TEE was determined.
Echocardiography. All but four subjects underwent multi-
plane color Doppler TEE with a Hewlett-Packard 2500 imag-
ing system (Andover, Massachusetts). Four subjects had trans-
thoracic echocardiography because of TEE refusal, pregnancy
or unsuccessful esophageal intubation. The aortic root and
heart valves were imaged at 4 to 8-cm depth settings and with
a narrow sector scan to improve image resolution. All studies
were coded by Social Security number, randomly intermixed
with those of controls and interpreted by an observer unaware
of clinical data.
Electronic calipers were used to measure by M-mode: (1)
the end diastolic thickness of the aortic root walls at the sinuses
and tubular portions from the longitudinal or short axis view;
(2) the aortic root diameters at the annulus, sinuses and
tubular levels (17); (3) the mitral leaflet thickness at the basal,
mid and tip portions from the four-chamber view and the aortic
cusps at their mid and thickest portions from the longitudinal
or short axis view; and (4) the end diastolic diameter of the mid
descending thoracic aorta. The aorto-mitral junction length
and height at the end diastole were measured using two-
dimensional images from the longitudinal view. All measure-
ments were averaged during three cardiac cycles.
From four to six blood pressure measurements during TEE
and the root diameters, aortic elasticity at the sinuses and
tubular portions were calculated by the Peterson’s pressure–
strain elastic modulus as 106 dynes cm22 and the pressure-
independent stiffness index (B) (18,19).
Criteria for echocardiographic interpretation. Aortic root
abnormalities were defined as 2 SD above the mean values
obtained for the controls (Table 2). Aortic root thickening was
defined as an anterior or posterior wall thickness of .2.2 mm.
Sinus or tubular aortic root dilatation was defined as .41 or
.35 mm, respectively. These diameters are above normal for
healthy subjects ,60 years old (17,20). Abnormal aortic root
pressure–strain elastic modulus and stiffness were defined as
.2.1 and .4.1 at the sinuses or .3.1 and .3.9 at the tubular
level, respectively. Subaortic bump was defined as an aorto-
mitral junction length and height of .7.7 and .3.2 mm,
respectively (Fig. 1A).
Valve thickening was defined as a thickness .3 mm for the
mitral valve or .2 mm for the aortic valve in at least two
leaflets, or in one leaflet if associated with at least mild
regurgitation of the respective valve (21) or if a subaortic bump
was present (for the mitral valve). Valve regurgitation assessed
by semiquantitive methods (22,23) was present if it was greater
than mild or if it was mild with thickening of the respective
valve.
Electrocardiography. All subjects had 12-lead electrocar-
diography.
Evolution of aortic root disease and valve disease. To
assess the evolution of cardiovascular disease, 25 patients had
repeat transthoracic echocardiography and electrocardiogra-
phy 39 6 10 months later. These evaluations were performed
.12 months after the initial TEE or at the time of complica-
tions. An observer unaware of initial results interpreted these
studies.
Morbidity and mortality. During follow-up of the same 25
patients, the incidences of heart failure, valve replacement,
infective endocarditis, stroke and death were determined.
Findings were compared with those of all controls followed for
50 6 16 months.
Statistical analysis. Student and paired t tests were used
for comparison of continuous variables, and analysis of vari-
ance was used to compare characteristics of the aortic root and
heart valves between groups after adjusting for smoking,
hypertension, diabetes or coronary artery disease (24). A
subset analysis of patients was done by analysis of variance with
Fisher’s least significant differences as post hoc tests. Fisher’s
exact and McNemar’s tests were used for comparison and
associations of categorical variables (25). To assess interrater
Abbreviations and Acronyms
AKS 5 ankylosing spondylitis
TEE 5 transesophageal echocardiography
Table 1. Clinical Characteristics*
Characteristic Patients (n 5 44) Controls (n 5 30)
Age (years) 46 6 10 44 6 8
Male/female 38/6 24/6
Body surface area (m2) 1.87 6 0.18 1.90 6 0.24
Systolic blood pressure (mm Hg) 130 6 17† 122 6 12
Diastolic blood pressure (mm Hg) 80 6 9‡ 74 6 9
Pulse pressure (mm Hg) 50 6 13 48 6 10
Smokers 25% 17%
Hypertension 17% 0
Diabetes mellitus 5% 0
Coronary artery disease 11% 0
Duration of the disease (years) 20 6 11
Peripheral arthritis 51%
History of anterior uveitis 28%
Positive HLA-B27 95%
*Plus–minus values are means 6 SD. †p 5 0.03 and ‡p 5 0.01 for
comparison between patients and controls. A total of 18 patients (41%) and 6
controls (17%) were either smokers or had hypertension, diabetes mellitus or
coronary artery disease (p 5 0.02 for comparison with controls).
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agreement for detecting cardiovascular disease, a second ob-
server interpreted 35 randomly selected TEE studies (20
patients and 15 controls). Interrater agreement was deter-
mined by the percentage of agreement as well as by Cohen’s
kappa test (26). A p value ,0.05 was considered significant.
Results
Characteristics of the aortic root and heart valves. In
patients the aortic root thickness, diameter and elasticity; the
aorto-mitral junction length and height; and the aortic and
mitral valve thickness were significantly different from those of
controls even after adjusting for smoking, hypertension, dia-
betes mellitus or coronary artery disease (Table 2).
Aortic root disease and valve disease. Aortic root disease
and valve disease were detected in 36 patients (82%) and 8
controls (27%) (p , 0.001) (Table 3).
Aortic root thickening and decreased elasticity, but not root
dilatation, were common in patients (61%) as compared with
controls (,10%) (p , 0.001). Most patients (78%) with root
thickening had decreased root elasticity, and most (73%) with
root dilatation had root thickening.
Valve thickening was frequent (48%) in patients and similar
for the mitral and aortic valves. Aortic valve thickening was
predominantly (72%) manifested as nodularities (up to 6 mm
in diameter), generally single, homogeneously echoreflectant,
with well-defined borders, located on any portion of the three
cusps (Fig. 1C) and unrelated to the patient’s age (logistic
regression, p 5 0.19). Diffuse thickening was uncommon, was
noted on the cusp margins and rarely caused decreased cusp
mobility. Mitral valve thickening was also common and pre-
dominantly localized (73%) to the basal anterior mitral leaflet,
forming a subaortic bump in most cases. The decreased
diastolic mobility of the basal anterior mitral leaflet, in contrast
to normally moving mid and distal portions, gave the leaflet the
appearance of an elbow (elbow sign) (Fig. 1B) (p , 0.001 for
the association of subaortic bump with elbow sign).
Valve regurgitation was also frequent (45%) in patients and
similar for the mitral and aortic valves. Eight (40%) of 20
patients with valve regurgitation had moderate lesions (aortic
in three and mitral in five). Seven patients (16%) had valve
prolapse: aortic in two and mitral in five (posterior leaflet in
two, anterior in one and both in two).
Aortic root disease and valve disease were interrelated
(73% to 100%, p , 0.02 for all associations). Most patients
with aortic valve thickening had root and mitral valve thicken-
ing, most with mitral valve thickening had root thickening and
subaortic bump, and all with subaortic bump had root thick-
ening. All patients with aortic regurgitation had root and valve
thickening, most with mitral regurgitation had valve thicken-
ing, and all with moderate aortic or mitral regurgitation had
subaortic bump (Figs. 1 and 2).
Of 35 TEE studies evaluated by a second observer, 66% had
aortic root or valve disease. There was an overall 85% agree-
ment for detecting aortic root disease (kappa 5 0.70) and an
overall 89% agreement for valve disease (kappa 5 0.77): 83%
for root thickening, 91% for dilatation, 82% for stiffness, 89%
for valve thickening, 93% for regurgitation and 85% for
subaortic bump.
Other cardiac findings. Sixteen patients (36%) had other
cardiac disease: 10 (23%) had conduction disturbances (left
bundle branch block in 3, right bundle branch block in 5,
Table 2. Characteristics on Transesophageal Echocardiography of the Aortic Root and Heart Valves
Characteristic Patients (n 5 44) Controls (n 5 30) p Value*
Aortic root wall thickness (mm)
Anterior 2.4 6 0.7 1.6 6 0.3 ,0.001
Posterior 2.7 6 0.9 1.6 6 0.4 ,0.001
Aortic root diameter (mm)
At the annulus in end diastole 23.5 6 4 21.7 6 2 0.02
At the sinuses level in end diastole 36 6 5 34 6 3 0.05
At the sinuses level in end systole 37 6 5 36 6 3 NS
Differential (diastolic minus systolic) 1.3 6 0.6 2.1 6 0.7 ,0.001
At the tubular level in end diastole 32 6 5 29 6 3 0.001
At the tubular level in end systole 34 6 5 32 6 3 0.02
Differential (diastolic minus systolic) 1.4 6 0.7 2.3 6 0.7 ,0.001
Aorto-mitral junction (mm)
Length 7 6 4 5 6 2 ,0.001
Height 3.2 6 1 2.6 6 0.3 ,0.001
Root stiffness index† 3.9 6 0.5 3.3 6 0.4 ,0.001
Ep (106 dynes/cm22)† 2.3 6 1.8 1.1 6 0.5 ,0.001
Valve thickness
Mitral 3.6 6 0.5 1.7 6 0.4 ,0.001
Aortic 3.2 6 0.5 1.0 6 0.3 0.02
*p Values were similarly significant for all characteristics between patients and controls when adjusted for smoking,
hypertension, diabetes mellitus or coronary artery disease, except for aortic root end diastolic diameter at the sinuses level
(p 5 0.06). †These two parameters were also significantly different between patients and controls when measured at the
sinotubular portion. Ep 5 Peterson’s pressure–strain elastic modulus.
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atrioventricular, nonspecific intraventricular or fascicular
block in 2 of them; and 8 had root thickening and subaortic
bump; five (11%) had coronary artery disease; two (5%) had
nonischemic cardiomyopathy; and 2 had left ventricular hyper-
trophy. Four controls (13%) had other cardiac disease: 3 had
conduction disturbances and 1 had left ventricular hypertrophy
(p 5 0.02 for patients vs. controls).
Relation of cardiovascular disease to clinical features of
AKS. To define an association with clinical features of AKS,
three groups were defined: those with aortic root disease and
Figure 1. (A) For illustration, this longitudinal transesophageal echo-
cardiography view in a 46-year-old healthy volunteer demonstrates
normal aortic root walls (small arrows), noncoronary cusps (ncc) and
right coronary cusps (rcc), aorto-mitral junction (arrow) and normal
mobility of the anterior mitral leaflet (aml). LA 5 left atrium; LV 5
left ventricle. (B) This transesophageal echocardiography view in a
44-year-old patient demonstrates moderate thickening of the aortic
root predominantly of the posterior wall (small arrows) extending to
the basal anterior mitral leaflet, forming a subaortic bump (arrows)
and markedly decreasing its mobility (elbow sign). Mild mitral regur-
gitation was demonstrated. (C) This transesophageal echocardiogra-
phy view of a 47-year-old patient demonstrates marked thickening of
the aortic root predominantly of the posterior wall and a prominent
subaortic bump (arrow) decreasing the mobility of the anterior mitral
leaflet. Small, homogeneously echoreflectant nodularities at the tip of
the noncoronary cusp (ncc) and right coronary cusp (rcc) (arrowheads)
are also noted. Associated mild aortic and mitral regurgitation was
demonstrated.
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valve disease (24 patients), those with aortic root disease or
valve disease (12 patients) and those with neither (8 patients).
All parameters of AKS activity and severity or therapy did not
differ according to the presence or severity of cardiovascular
disease. However, most patients .45 years old with AKS duration
of .15 years had aortic root or valve disease (Table 4).
Evolution of cardiovascular disease. Six of 25 patients
(24%) developed new or other aortic root or valve abnormal-
Table 3. Frequency of Aortic Root and Valve Abnormalities on Transesophageal Echocardiography
Abnormality
Patients (n 5 44) Controls (n 5 30)
n % n % p Value
Aortic root abnormalities
Thickening 27 61 2 7 ,0.001
Dilatation 11 25 2 7 0.06
Abnormal Ep or stiffness 27 61 3 10 ,0.001
Valve abnormalities
Thickening 21 48 3 10 ,0.001
Aortic 18 41 3 10 0.04
Mitral 15 34 1 3 ,0.001
Subaortic bump 11 25 0 0 0.002
Regurgitation 20 45 1 3 ,0.001
Aortic 7 16 0 0 0.02
Mitral 14 32 1 3 0.003
Tricuspid 1 2 0 0
Any 36 82 8 27 ,0.001
Ep 5 Peterson’s pressure–strain elastic modulus.
Figure 2. (A) This preoperative short axis transesoph-
ageal echocardiography view of the aortic valve in a
34-year-old patient demonstrates thickening of the
aortic root walls (small arrows) and irregular thicken-
ing of the three aortic cusp tips (arrowheads). Severe
aortic regurgitation with a central jet was demon-
strated. (B) This panel demonstrates retracted, rolled
noncoronary cusp (ncc) and right coronary cusp (rcc)
and irregularly thickened margins of the three aortic
cusps (arrowheads). A central regurgitant orifice was
confirmed. lcc 5 left coronary cusp.
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ities. In three other patients (12%) valve regurgitation pro-
gressed from moderate or less to severe regurgitation in two
(one with mitral and one with aortic) and from mild to
moderate aortic regurgitation in the third. In five patients
(20%) aortic root or valve abnormalities resolved during
follow-up. One patient developed a new conduction distur-
bance.
Morbidity and mortality. Before entry into the study, one
patient had had aortic valve replacement for severe regurgita-
tion. At surgery the aortic root was moderately dilated and the
aortic cusps were thickened and retracted. Pathology showed
cusp fibrosis and mucinoid degeneration. A second patient had
had mitral valve repair and annuloplasty for severe regurgita-
tion due to a flail myxomatous posterior leaflet. A third patient
had had mitral valve replacement for severe regurgitation due
to chronic valvulitis. In these three patients surgery confirmed
preoperative TEE findings.
During follow-up five patients (20%) developed seven
complications. A 34-year-old man underwent aortic valve
replacement for severe regurgitation and heart failure. The
aortic root and annulus were moderately dilated and the three
cusps were thickened and retracted, forming a central regur-
gitant jet. These findings matched the preoperative TEE (Fig.
2). Pathology showed cusps nodular thickening and fibrosis but
no inflammation. A 50-year-old man with a previously replaced
aortic valve and residual diffuse thickening of the anterior
mitral leaflet developed severe mitral regurgitation and heart
failure, but refused valve surgery. A 52-year-old woman with a
small mass of low echoreflectance on the aortic noncoronary
cusp developed two transient ischemic attacks. A 41-year-old
man with root thickening and dilatation but no valve disease
had a stroke. These last two patients had no aortic atheroma,
atrial pseudocontrast or anticardiolipin antibodies. Finally, a
55-year-old man with a normal TEE died from a subarachnoid
hemorrhage. A 55-year-old woman control subject (3%) with a
normal TEE developed hypertension and a transient ischemic
attack (p 5 0.08, patients vs. controls).
Discussion
Major findings. Aortic root disease and valve disease in
patients with AKS: (1) are common, are interrelated and have
unique TEE characteristics; (2) are unrelated to clinical fea-
tures of AKS with the exception of patients’ age and duration
of AKS; and (3) show resolution or progression over time and
are associated with clinically important cardiovascular morbid-
ity.
Pathogenesis and comparison with postmortem studies.
The cellular inflammation of the first 3 cm of the aortic root
results in a marked fibroblastic reparative response, adventitial
thickening, focal destruction of the medial elastic tissue and
intimal proliferation. The surrounding inflammation and inti-
mal proliferation of the vasa vasora lead to obliterative end-
arteritis and then to root dilatation. This process extends to the
aortic annulus and produces basal thickening and downward
retraction of the cusps. These chronic or acute changes of the
aortic root and valve lead to aortic regurgitation (1,2,27).
Extension of the fibrosis into the aorto-mitral junction forms a
subvalvular fibrous ridge or subaortic bump. Mitral regurgita-
tion also results from chronic or acute valvulitis, but its
association with a subaortic bump was not well defined.
Further extension of fibrosis into the proximal septum and
Table 4. Clinical Characteristics of Patients According to the Presence or Absence of Aortic Root
Disease and/or Valve Disease
Clinical Characteristic
Aortic Root Disease and
Valve Disease (n 5 24)
Aortic Root Disease or
Valve Disease (n 5 12)
Neither
(n 5 8)
Age (yrs)* 50 6 7 44 6 9 40 6 14
Duration of the disease (yrs)† 24 6 10 14 6 7 16 6 14
BASDAI 5.3 6 2.2 6.6 6 2.3 6.4 6 2.1
BASFI 6 6 2.7 6.9 6 2.5 6.2 6 2.3
BASG 6 6 2.5 7.4 6 3 6.2 6 4
BASMI 3.7 6 2.1 3.8 6 2 6 6 1.7
SASSS of lumbar spine disease 26 6 23 21 6 18 33 6 22
Sacroiliac joint disease 3.4 6 1.3 2.5 6 1.6 2.4 6 1.7
Laboratory score 1.2 6 0.9 1.3 6 1.2 1.7 6 1.4
Erythrocyte sedimentation rate (mm/h) 18 6 19 17 6 18 27 6 17
C-reactive protein (mg/dl) 1.4 6 1.3 0.9 6 1 1.7 6 2.4
High anticardiolipin antibodies 8% 33% 29%
Peripheral arthritis 57% 60% 75%
History of anterior uveitis 14% 25% 33%
NSAIDS 71% 92% 96%
Sulfasalazine therapy 14% 17% 17%
Steroids or cytotoxics 14% 8% 8%
Plus–minus values are means 6 SD. *p 5 0.03 for those with aortic root disease and valve disease versus those with
neither. †p 5 0.01 for those with aortic root disease and valve disease versus those with either. BASDAI, BASFI, BASG
and BASMI 5 Bath ankylosing spondylitis activity, functional, global and metrology indexes, respectively. SASSS 5 Stoke
ankylosing spondylitis spine score.
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atrioventricular node leads to conduction disturbances. How-
ever, the antigenic trigger, the pathogenesis of inflammation
and the selective involvement of the left heart skeleton and
proximal aorta are unknown.
The aortic root disease and valve disease described in this
study correspond to those described in pathology (1,2). How-
ever, in this study aortic root thickening was more common
than dilatation (61% vs. 25%, respectively) and dilatation was
usually mild. Also, aortic valve thickening was usually localized
instead of diffuse. In addition, an association of structural with
functional aortic root disease and valve disease was estab-
lished. Root thickening was associated with increased stiffness,
and these abnormalities in addition to aortic valve thickening
or prolapse, but not root dilatation, were associated with aortic
regurgitation. Also, all patients with at least moderate regur-
gitation had subaortic bump. The subaortic bump decreased
the mobility and may have caused anterior mitral leaflet
retraction, asymmetric or incomplete coaptation and a relative
or true leaflet prolapse. Finally, conduction disturbances were
associated with aortic root thickening or subaortic bump.
Comparison with previous echocardiographic studies. Pre-
vious transthoracic echocardiographic series (3–7,28) reported
a lower prevalence of aortic root disease and valve disease (8%
to 31%). The abnormalities described were subjectively as-
sessed and were frequently nonspecific, and an interrelation
between aortic root disease and valve disease was not well
defined. In addition, aortic root stiffness was not reported and
the mechanisms of valve regurgitation were not described. The
use of a less sensitive echocardiographic technique, the inclu-
sion of patients .60 years old, the qualitative definition of root
and valve abnormalities and the lack of control for other
conditions associated with aortic root disease and valve disease
may explain these differences.
Relation of cardiovascular disease to clinical features of
AKS. The presence and severity of aortic root disease and
valve disease were temporally dissociated from the activity,
severity or therapy of AKS, but were associated with the
patients’ age or duration of AKS. Previous series (3,5,7,29)
using less objective clinical evaluations also suggested a disso-
ciation. Similar dissociation appears to exist with pulmonary or
eye disease associated with AKS (30,31).
The dissociation between cardiovascular disease and the
clinical features of AKS is probably explained by several
factors.
1. A highly sensitive technique for detecting mild cardiovas-
cular abnormalities in outpatients with a wide spectrum of
duration, activity and severity of AKS is applied.
2. The currently utilized clinical and radiographic parameters
of activity and severity of AKS may not be sensitive or
specific (32,33). Elevation of the erythrocyte sedimentation
rate or C-reactive protein occurs in only 30% to 60% of
patients with severe AKS (32,34).
3. The cardiovascular and skeletal inflammation may be tem-
porally dissociated or may be triggered by different target
antigens.
4. In contrast to other connective tissue diseases, AKS is
frequently subclinically active or symptomatically regressive
(32,34).
Thus, the traditional parameters of skeletal inflammation of
AKS cannot be utilized as markers of cardiovascular disease.
Evolution of aortic root disease and valve disease. During
follow-up, up to 24% of patients developed new or other aortic
root or valve abnormalities, in 12% valve regurgitation pro-
gressed significantly and in 20% abnormalities resolved. These
changes may be related to intermittent, recurrent or persistent
aortitis or valvulitis. Similar changes have been observed in the
immune-mediated valve disease of systemic lupus erythemato-
sus and rheumatic fever (21,35).
Morbidity. Seven patients had complications related to
aortic root disease or valve disease. Five patients required
valve surgery for severe valve dysfunction, but one declined it;
two patients developed cerebral ischemic events. In the four
patients who had valve surgery, surgical findings confirmed
those of preoperative TEE. This increased cardiovascular
morbidity in patients with AKS may account for their higher
than expected mortality at 10 years of follow-up (36).
Study limitations. The study of 71% of eligible patients
may have skewed the study results toward an overestimation of
the prevalence and morbidity of the cardiovascular disease
associated with AKS. The study of a larger population with
longer follow-up is necessary to better assess our findings. The
comparison of TEE with follow-up precordial echocardiogra-
phy may decrease the validity of the observed changes of aortic
root disease and valve disease.
Clinical implications. Aortic root stiffness may cause hy-
pertension or increased left ventricular afterload, leading to
ventricular hypertrophy and diastolic dysfunction. In this study
patients had higher systolic and diastolic blood pressures than
controls. Previous series have reported a high prevalence
(20%) of systemic hypertension (4) and of left ventricular
diastolic dysfunction (20% to 43%) in nonhypertensive pa-
tients with AKS ,45 years old (29,37).
The most feared consequence of valve disease is progres-
sion to severe valve dysfunction and the need for valve
replacement. In this study four of five patients with severe
valve regurgitation underwent valve replacement. However,
also in this study no clinical predictors other than duration of
AKS were predictive of the presence, severity and progression
of cardiovascular disease.
Aortic root or valve lesions may be a substrate for cardio-
embolism. In two patients with cerebral ischemic events, an
aortic valve mass in one and aortic root thickening and
dilatation in the other were the only possible substrates.
Although a causal relation with embolism could not be estab-
lished, an association is possible. Studies of the natural history
of AKS have demonstrated that cerebrovascular disease is a
common cause of mortality in patients ,60 years old (36).
Thus, while awaiting the study of larger populations with a
longer follow-up, prophylactic antiplatelet therapy may be
indicated in these patients. Infective endocarditis is another
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reported complication of asymptomatic valve disease associ-
ated with AKS (38).
In this study most patients had asymptomatic aortic root
disease and valve disease, but 40% of those with valve regur-
gitation had moderate lesions and in another 12% valve
regurgitation progressed significantly. Also, patients $45 years
old with an AKS duration of $15 years had the highest
prevalence of cardiovascular disease. Therefore, these patients
should be approached with high clinical suspicion, and a
careful cardiovascular history and physical examination should
be the preferred screening method for detecting significant
valve disease (39). Finally, serial clinical or echocardiographic
follow-up of patients with AKS and aortic root disease or valve
disease appears warranted.
We thank Frank T. Gurule, Aggie M. Schaeffer and Kristine E. Councilman for
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